The new FDA guidelines for AI in healthcare, effective January 2026, aim to establish a robust regulatory framework for AI-driven medical devices, ensuring safety, efficacy, and trustworthiness for patients and providers in the United States.
New federal cybersecurity mandates are anticipated by June 2026, profoundly affecting US businesses. Proactive understanding and strategic preparation are crucial to ensure compliance and strengthen digital defenses against evolving threats.